Literature DB >> 20722493

Personal factors associated with reported benefits of Huntington disease family history or genetic testing.

Janet K Williams1, Cheryl Erwin, Andrew Juhl, James Mills, Bradley Brossman, Jane S Paulsen.   

Abstract

AIMS: A family history of Huntington disease (HD) or receiving results of HD predictive genetic testing can influence individual well-being, family relationships, and social interactions in positive and negative ways. The aim of this study was to examine benefits reported by people with an HD family history or those who have undergone predictive HD testing, as well as the personal variables associated with perceived benefits.
METHODS: Seventy-four of 433 people completing the International Response of a Sample Population to HD risk (I-RESPOND-HD) survey reported benefits. Knowledge and understanding was perceived as the most common benefit from participants in both groups. The next most frequent perceived benefits from a family history were connecting with others and achieving life meaning and insights. The next most common perceived benefits from genetic testing were life planning and social support. The least common perceived benefit for both groups was renewed hope and optimism. Older age and spirituality were significantly associated with benefits in both groups.
CONCLUSIONS: Perceptions of benefit may not be as likely until later years in people with prodromal HD. A developed sense of spirituality is identified as a personal resource associated with the perception of benefit from genetic testing for HD. Associations among spirituality, perceived benefits, and other indicators of personal and family well-being may be useful in genetic counseling and health care of people with prodromal HD.

Entities:  

Mesh:

Year:  2010        PMID: 20722493      PMCID: PMC2957234          DOI: 10.1089/gtmb.2010.0065

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  43 in total

Review 1.  Psychological impact of genetic testing for Huntington's disease: an update of the literature.

Authors:  B Meiser; S Dunn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

2.  Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat.

Authors:  S M Miller
Journal:  J Pers Soc Psychol       Date:  1987-02

3.  At risk for Huntington disease: The PHAROS (Prospective Huntington At Risk Observational Study) cohort enrolled.

Authors: 
Journal:  Arch Neurol       Date:  2006-07

Review 4.  A life-span theory of control.

Authors:  J Heckhausen; R Schulz
Journal:  Psychol Rev       Date:  1995-04       Impact factor: 8.934

5.  Attachment in families with Huntington's disease. A paradigm in clinical genetics.

Authors:  Lucienne Van der Meer; Reinier Timman; Wim Trijsburg; Marleen Duisterhof; Ruud Erdman; Thérèse Van Elderen; Aad Tibben
Journal:  Patient Educ Couns       Date:  2006-01-20

6.  In their own words: reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND-HD study.

Authors:  Janet K Williams; Cheryl Erwin; Andrew R Juhl; Michelle Mengeling; Yvonne Bombard; Michael R Hayden; Kimberly Quaid; Ira Shoulson; Sandra Taylor; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-09       Impact factor: 3.568

7.  Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study.

Authors:  Cheryl Erwin; Janet K Williams; Andrew R Juhl; Michelle Mengeling; James A Mills; Yvonne Bombard; Michael R Hayden; Kimberly Quaid; Ira Shoulson; Sandra Taylor; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-07       Impact factor: 3.568

8.  Fear of health insurance loss among individuals at risk for Huntington disease.

Authors:  Emily Oster; E Ray Dorsey; Jan Bausch; Aileen Shinaman; Elise Kayson; David Oakes; Ira Shoulson; Kimberly Quaid
Journal:  Am J Med Genet A       Date:  2008-08-15       Impact factor: 2.802

9.  On Quantitizing.

Authors:  Margarete Sandelowski; Corrine I Voils; George Knafl
Journal:  J Mix Methods Res       Date:  2009-07-01

10.  Predictive testing for Huntington's disease: relationship with partners after testing.

Authors:  M Decruyenaere; G Evers-Kiebooms; T Cloostermans; A Boogaerts; K Demyttenaere; R Dom; J P Fryns
Journal:  Clin Genet       Date:  2004-01       Impact factor: 4.438

View more
  16 in total

1.  Dispositional optimism and perceived risk interact to predict intentions to learn genome sequencing results.

Authors:  Jennifer M Taber; William M P Klein; Rebecca A Ferrer; Katie L Lewis; Leslie G Biesecker; Barbara B Biesecker
Journal:  Health Psychol       Date:  2014-10-13       Impact factor: 4.267

2.  Deaf genetic testing and psychological well-being in deaf adults.

Authors:  Christina G S Palmer; Patrick Boudreault; Erin E Baldwin; Michelle Fox; Joshua L Deignan; Yoko Kobayashi; Yvonne Sininger; Wayne Grody; Janet S Sinsheimer
Journal:  J Genet Couns       Date:  2013-02-21       Impact factor: 2.537

3.  Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

Authors:  Jane S Paulsen; Jeffrey D Long; Christopher A Ross; Deborah L Harrington; Cheryl J Erwin; Janet K Williams; Holly James Westervelt; Hans J Johnson; Elizabeth H Aylward; Ying Zhang; H Jeremy Bockholt; Roger A Barker
Journal:  Lancet Neurol       Date:  2014-11-03       Impact factor: 44.182

Review 4.  Personal utility in genomic testing: a systematic literature review.

Authors:  Jennefer N Kohler; Erin Turbitt; Barbara B Biesecker
Journal:  Eur J Hum Genet       Date:  2017-03-15       Impact factor: 4.246

5.  The ever-evolving concept of clinical significance and the potential for sins of omission in genetic research.

Authors:  Gregory Costain; Anne S Bassett
Journal:  Am J Bioeth       Date:  2012       Impact factor: 11.229

6.  Information Avoidance Tendencies, Threat Management Resources, and Interest in Genetic Sequencing Feedback.

Authors:  Jennifer M Taber; William M P Klein; Rebecca A Ferrer; Katie L Lewis; Peter R Harris; James A Shepperd; Leslie G Biesecker
Journal:  Ann Behav Med       Date:  2015-08

7.  Analysis of the Reasons for Non-Uptake of Predictive Testing for Huntington's Disease in Spain: A Qualitative Study.

Authors:  Jesús Rivera-Navarro; Esther Cubo; Natividad Mariscal
Journal:  J Genet Couns       Date:  2015-04-30       Impact factor: 2.537

8.  Prospective Evaluation of Predictive DNA Testing for Huntington's Disease in a Large German Center.

Authors:  Aysegül Ibisler; Sebastian Ocklenburg; Susanne Stemmler; Larissa Arning; Jörg T Epplen; Carsten Saft; Sabine Hoffjan
Journal:  J Genet Couns       Date:  2017-03-30       Impact factor: 2.537

9.  Two decades of Huntington disease testing: patient's demographics and reproductive choices.

Authors:  Rebekah C Krukenberg; Daniel L Koller; David D Weaver; Jennifer N Dickerson; Kimberly A Quaid
Journal:  J Genet Couns       Date:  2013-05-25       Impact factor: 2.537

10.  Perception, experience, and response to genetic discrimination in Huntington's disease: the Australian results of The International RESPOND-HD study.

Authors:  Anita M Y Goh; Edmond Chiu; Olga Yastrubetskaya; Cheryl Erwin; Janet K Williams; Andrew R Juhl; Jane S Paulsen
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.